BB Biotech AG (BION.SW) stock: key figures, P/E, revenue and dividend

Health Care · Switzerland · ISIN CH0038389992

Price
51.30 CHF
Market cap
2.81 bn CHF
P/E (2025)
4.89
P/S (2025)
37.02
Dividend yield
4.39 %
Net margin
760.53 %
Return on equity (ROE)
20.88 %
Return on assets (ROA)
20.78 %

BB Biotech AG financials

Fiscal year20242025
Revenue111.00 m CHF76.00 m CHF
Gross profit111.00 m CHF76.00 m CHF
Operating income80.33 m CHF586.45 m CHF
EBIT84.00 m CHF586.00 m CHF
Net income75.00 m CHF578.00 m CHF
Diluted EPS – continuing operations1.39 CHF10.48 CHF

Full history since 1995, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About BB Biotech AG

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.